| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $2,651,025 ) |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01MH132226 | Probing brain circuit and behavior with protein:protein interaction modulators | 000 | 2 | NIH | 11/29/2023 | $714,809 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM148364 | Mechanisms for the high fidelity of translesion synthesis by Y-family DNA polymerases in human cells | 000 | 2 | NIH | 11/9/2023 | $388,626 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | DP2AI154410 | Revealing the Biophysics of the Germinal Center Microenvironment | 000 | 3 | NIH | 11/9/2023 | $432,001 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R03HD108495 | Developing IL-10 encapsulated exosomes as novel therapeutics for spontaneous preterm birth | 000 | 2 | NIH | 11/8/2023 | $72,000 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | T35AI078878 | Infectious Diseases and Inflammatory Disorders Training Program | 000 | 14 | NIH | 11/7/2023 | $66,385 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01HD107428 | Human placental biodisposition of novel antiherpesviral drugs, amenamevir and pritelivir, using ex vivo and in vitro experimental models | 000 | 2 | NIH | 11/22/2023 | $24,526 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DK132072 | Targeting bone marrow to treat renal disease | 001 | 2 | NIH | 11/24/2023 | $460,756 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01CA247595 | Bimodal Intraoral imaging device for detection of oral epithelial neoplasia | 000 | 5 | NIH | 11/16/2023 | $421,504 |
| | 2024 | 2024 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI158422 | Ehrlichia Notch SLiM-activated oncoprotein inhibition of apoptosis | 000 | 3 | NIH | 11/3/2023 | $360,000 |
| | 2024 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K12AR084228 | UTMB Women's Health Research Scholars Program | 000 | 20 | NIH | 10/27/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K01OH012107 | Examining the Physical, Mental, and Social Health Outcomes Among Commercial Fishers to Inform Policy and Practice | 01 | 3 | CDC | 11/16/2023 | -$108,000 |
| | 2024 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K01AG065492 | Chronic Care Management of Geriatric Traumatic Brain Injury | 000 | 4 | NIH | 11/30/2023 | -$19,786 |
| | 2024 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | F31AT011856 | Determinants and effectiveness of non-pharmacologic pain interventions versus prescription opioids | 000 | 2 | NIH | 10/27/2023 | -$22,783 |
| | 2024 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI178318 | Targeting HNF4-induced thrombo-inflammation in Chagas disease | 000 | 1 | NIH | 11/6/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | 90IFRE0079 | Interplay of Physiological, Psychosocial, and Functional Outcomes in Burn Survivors. | 02 | 1 | ACL | 10/11/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | H4B15558 | Poison Control Stabilization and Enhancement Program | 02 | 15 | HRSA | 10/16/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U3REP220679 | Regional Emerging Special Pathogen Treatment Center Cooperative Agreement | 01 | 2 | ASPR | 11/15/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | P30AG059301 | The Texas Resource Center on Minority Aging Research (RCMAR) | 000 | 6 | NIH | 11/16/2023 | $0 |
| | 2024 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U01AI151807 | Coordinating Research on Emerging Arboviral Threats Encoing the Neotropics (CREATE-NEO) | 000 | 4 | NIH | 11/1/2023 | $0 |
| | 2024 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K01OH012107 | Examining the Physical, Mental, and Social Health Outcomes Among Commercial Fishers to Inform Policy and Practice | 01 | 3 | CDC | 11/16/2023 | -$19,588 |
| | 2024 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI146681 | Defining the roles of an enhancer long non-coding RNA eIncRNA-ID2 in rickettsial pathogenesis and immunity | 000 | 2 | NIH | 11/17/2023 | $0 |
| | 2024 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI125434 | Hydrogen Sulfide and NRF2 Cross-talk in Viral Infections | 000 | 5 | NIH | 11/8/2023 | $0 |
| | 2024 | 2022 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI087856 | MECHANISM OF RNA SYNTHESIS AND 5'-CAPPING BY DENGUE VIRUS NS5 POLYMERASE | 000 | 10 | NIH | 10/26/2023 | -$88,321 |
| | 2024 | 2021 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K01OH012107 | Examining the Physical, Mental, and Social Health Outcomes Among Commercial Fishers to Inform Policy and Practice | 01 | 3 | CDC | 11/16/2023 | $0 |
| | 2024 | 2020 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21DA047643 | Kinetics of Ligand Binding in Dopamine D1 Receptor Biased Signaling | 000 | 2 | NIH | 11/9/2023 | -$6,801 |
| | 2024 | 2020 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI142569 | Modulation of the Allergenicity of Cedar and Ragweed Pollen Major Allergens | 000 | 2 | NIH | 10/23/2023 | -$57 |
| | 2024 | 2020 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI140569 | Role of Pellino-1 in COVID-19 diseases | 000 | 2 | NIH | 10/16/2023 | $0 |
| | 2024 | 2020 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AI137779 | Sonic Hedgehog Regulation of Apoptosis During Ehrlichia Infection | 000 | 2 | NIH | 10/18/2023 | -$406 |
| | 2024 | 2020 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AG069226 | tRNA-derived RNA Fragments, A New Regulator for Alzheimer's Disease | 000 | 1 | NIH | 10/24/2023 | $0 |
| | 2024 | 2020 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R21AG063056 | Development of NNMT inhibitors as novel interventions to activate quiescent muscle stem cells and improve age-related muscle degeneration | 000 | 2 | NIH | 11/22/2023 | -$12,812 |
| | 2024 | 2020 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U18DA052504 | FGF13: a novel druggable target for treating substance abuse disorders | 000 | 1 | NIH | 11/17/2023 | -$2,304 |
| | 2024 | 2019 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | U18EB029353 | Development of a Wireless Endovascular Nerve Stimulator for Treatment ofRefractory Neuropathic Pain | 000 | 2 | NIH | 10/31/2023 | $0 |
| | 2024 | 2019 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | P2CHD065702 | Center for Large Data Research and Data Sharing in Rehabilitation | 000 | 10 | NIH | 10/11/2023 | -$8,723 |
|
| Issue Date FY: 2023 ( Subtotal = $114,001,288 ) (Continued on the next page) |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K12HD052023 | UTMB Women's Health Research Scholars Program | 001 | 19 | NIH | 7/12/2023 | $0 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K12AR084228 | UTMB Women's Health Research Scholars Program | 000 | 20 | NIH | 7/25/2023 | $1 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AI176670 | Porous silicon microparticle-based subunit vaccines for SARS-CoV-2 | 000 | 1 | NIH | 2/9/2023 | $613,059 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01EY034376 | CXCR3-Mediated Cell-Cell Communication in Glaucoma | 001 | 2 | NIH | 7/31/2023 | $459,717 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | D43TW012246 | Training and Research on Arboviruses and Zoonoses In Nigeria and Sierra Leone (TRAIN) | 000 | 2 | NIH | 2/16/2023 | $198,400 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | T32AG067952 | Predoctoral and Postdoctoral Training in Alzheimer's Pathophysiology | 000 | 3 | NIH | 6/9/2023 | $349,096 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01DA052263 | AIM(2)ing at the inflammasome: Impact of MAVS signaling in cocaine-and HIV-1 induced neuroinflammation | 000 | 3 | NIH | 2/17/2023 | $593,890 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01GM139034 | Structural and functional determinants of decision-making in bacteriophage host recognition | 001 | 4 | NIH | 7/24/2023 | $142,740 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | P30AG059301 | The Texas Resource Center on Minority Aging Research (RCMAR) | 002 | 6 | NIH | 8/22/2023 | $694,253 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01HD083445 | Long-term effectiveness of a middle school dating violence prevention evaluation with and without an SMS booster. | 000 | 7 | NIH | 8/29/2023 | $640,802 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | K12HD052023 | UTMB Women's Health Research Scholars Program | 001 | 19 | NIH | 7/12/2023 | $0 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | 90IFRE0079 | Interplay of Physiological, Psychosocial, and Functional Outcomes in Burn Survivors. | 01 | 1 | ACL | 9/27/2023 | $0 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | 90IFRE0079 | Interplay of Physiological, Psychosocial, and Functional Outcomes in Burn Survivors. | 00 | 1 | ACL | 8/25/2023 | $199,998 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R35GM151324 | Dissecting the Mechanisms of Quaking-Regulated RNA Processing | 000 | 1 | NIH | 7/25/2023 | $400,000 |
| | 2023 | 2023 | UNIVERSITY OF TEXAS MEDICAL BRANCH AT GALVESTON | 301 UNIVERSITY BLVD | GALVESTON | TX | 77555-5302 | GALVESTON | USA | R01AG075208 | Identifying the Causes of the Stagnation in National U.S. Cardiovascular Disease Mortality | 000 | 1 | NIH | 2/9/2023 | $318,215 |
|
